Open AccessA qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006)
Author(s) -
L.A. Gharzai,
Lauren A. Szczygiel,
Dean A. Shumway,
Hanna Bandos,
Thomas B. Julian,
Eleftherios P. Mamounas,
Julia White,
Jennifer F. De Los Santos,
Mark Basik,
Patricia A. Ganz,
Reshma Jagsi
Publication year - 2021
Publication title -
breast cancer research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.908
H-Index - 154
eISSN - 1573-7217
pISSN - 0167-6806
DOI - 10.1007/s10549-021-06172-0
Subject(s) - medicine , breast cancer , lumpectomy , surgical oncology , mastectomy , oncology , specialty , clinical trial , neoadjuvant therapy , multidisciplinary approach , family medicine , systemic therapy , qualitative research , cancer , social science , sociology
Accrual to clinical trials that challenge well-established treatment paradigms represents a unique challenge. Physician opinions on investigation of a novel approach to breast cancer treatment, in which patients with complete response to neoadjuvant chemotherapy are offered omission of lumpectomy, are unknown. NRG-CC006 sought to describe physician attitudes toward a novel approach to breast cancer treatment.